Go to top of page

ANSTO statement on corporate governance

During the 2019-2020 financial year, the Board worked closely with Management on continuing to improve ANSTO’s corporate governance, accountability and risk management practices to ensure that ANSTO is able to deliver essential research, nuclear medicines and other products and services safely and sustainably for the benefit of all Australians.